ZIC2 promotes proliferation, migration, invasion, epithelial-mesenchymal transition (EMT) and affects the cell cycle of ccRCC cells in vitro and in vivo. This evidence concerns the gene ZIC2 and nonpapillary renal cell carcinoma.